TRIO Partners with eClinical Solutions to Power Digital Transformation in Clinical Trials for Cancer
MANSFIELD, MASS. (PRWEB) APRIL 15, 2021 eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services that accelerate digital clinical initiatives, today announced that Translational Research in…
Read more
Translational Research in Oncology (TRIO) Named Top Alberta Employer for Second Year
Translational Research in Oncology (TRIO), a global academic clinical research organization, is pleased to be recognized as one of Alberta’s Top 70 Employers, an editorial competition that recognizes Alberta’s best…
Read more
Translational Research in Oncology (TRIO) Enrolls First Patient in Early Breast Cancer Phase 2 Trial
Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of the first patient in a Phase 2 randomized, multi-center, open-label clinical trial of GDC-9545 sponsored…
Read more
Translational Research In Oncology (TRIO) Appoints Industry And Clinical Experts To Board Of Directors
Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced the appointment of two new members to the Company’s Board of Directors, effective February 1, 2020. Joining…
Read more
Translational Research In Oncology (TRIO) Initiates Phase I Study For MT-5111
Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced enrollment of the first patient in a Phase I study with its partner Molecular Templates (Nasdaq: MTEM).…
Read more
TRIO Partners With Molecular Templates For First-In-Human Phase I Study For MT-5111
Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced it has partnered with Molecular Templates (Nasdaq: MTEM) to conduct its First-in-Human study for patients with previously…
Read more
TRIO Enrolls First Patient Into PHASE III NATALEE Clinical Trial
– Timely Enrolment Signifies Milestone in TRIO – EDMONTON, Alberta (January 14, 2019) – Translational Research In Oncology (TRIO), in collaboration with Novartis and under the direction of Dennis Slamon,…
Read more
TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History
Ribociclib Combination Therapy in Adjuvant Setting Represents A Promising Therapy Against Breast Cancer EDMONTON, ALBERTA (July 9, 2018) – Translational Research In Oncology (TRIO) today announced a collaboration with Novartis…
Read more